期刊
NEURON
卷 101, 期 5, 页码 774-778出版社
CELL PRESS
DOI: 10.1016/j.neuron.2019.02.005
关键词
-
资金
- Department of Veterans Affairs (National Center for PTSD)
- NIAAA Center for the Translational Neuroscience of Alcohol [P50AA12870]
- Yale Center for Clinical Investigation [UL1 RR024139]
- Brain and Behavior Research Foundation
- NIMH [MH045481, MH093897, MH077681]
- State of Connecticut
- [P01HL131478]
Ketamine is the first exemplar of a rapid-acting antidepressant with efficacy for treatment-resistant symptoms of mood disorders. Its discovery emerged from a reconceptualization of the biology of depression. Neurobiological insights into ketamine efficacy shed new light on the mechanisms underlying antidepressant efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
